The effects of different familial Alzheimer's disease mutations on APP processing in vivo. - Test2 - elhamkhani - TriplyDB

The effects of different familial Alzheimer's disease mutations on APP processing in vivo.

The effects of different familial Alzheimer's disease mutations on APP processing in vivo.

http://www.wikidata.org/entity/Q37645358

about

The therapeutic potential of resveratrol: a review of clinical trials.

P2860

Q55151370-4091CA79-B225-411F-B9A6-25D7F3EC9D8C

P2860

The effects of different familial Alzheimer's disease mutations on APP processing in vivo.

http://www.wikidata.org/entity/Q37645358

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The effects of different famil ...... ons on APP processing in vivo.

@en

The effects of different famil ...... ons on APP processing in vivo.

@nl

type

label

The effects of different famil ...... ons on APP processing in vivo.

@en

The effects of different famil ...... ons on APP processing in vivo.

@nl

prefLabel

The effects of different famil ...... ons on APP processing in vivo.

@en

The effects of different famil ...... ons on APP processing in vivo.

@nl

P1433

Q37645358-14684F0E-221D-4C43-B6F2-0E5790F4E166

P1476

Q37645358-6F595A40-644A-4B26-8E09-B74B503DEDE3

P2093

Q37645358-8BA22926-19DF-4E28-ACFB-7D37CD20D370

Q37645358-C2028F65-0A8D-4218-8E92-9A0669AFF5B4

Q37645358-C236B007-8ABE-4D25-9E3D-876C0D2822EB

P2860

Q37645358-13AF74D5-49CD-4C5F-BFDB-0C44F715D8F3

Q37645358-196B4C98-97F6-49E6-AB26-F63896DFB041

Q37645358-20F1A642-3AE0-46CD-9467-D0B7721CE252

Q37645358-24365254-ACCB-4012-BFD4-534B426B947B

Q37645358-251549FE-3027-445D-A1EA-E717A1DD6EF7

Q37645358-2693D760-67A1-4644-AE8C-1283FBCC08B6

Q37645358-2C7CE487-6BD2-4591-A518-CEC8C89FEBF4

Q37645358-2D6C4B42-EA87-49C0-961F-ACF1517A85A0

Q37645358-30956F83-8783-4391-B8C0-D90A215CA821

Q37645358-30A54DCF-61EE-442C-AF69-30F492D22ADA

P2888

Q37645358-4E2F706A-B9F8-49A2-B044-B1ED1B97E7C9

P304

Q37645358-DD85739E-FF78-4764-943D-B785E29F308A

P31

Q37645358-B84FF109-236A-4575-9362-884EECB99CAC

P356

Q37645358-C50BA880-88DE-4C7D-B085-3C3332369416

P407

Q37645358-EC4CA421-B56D-4784-981E-24E0ABDE1224

P433

Q37645358-2B7F6F96-7111-424F-97C9-CA9DCEC746B9

P478

Q37645358-4428246E-C123-44F6-9C28-2BDDD81A2E5E

P50

Q37645358-42938F29-1E08-4154-8AD8-B18572587D2C

Q37645358-AD3B71AB-24B8-491E-8DFE-87E205BF0DA6

Q37645358-AE48EBE3-898F-4A45-849F-861A31259862

Q37645358-E8B4E455-5C2E-46E9-A1EB-225299E65AF0

Q37645358-EB32F1AA-E2DD-4B38-8554-069F54716A67

P577

Q37645358-2B227492-5A0D-4FE4-8B3E-E1B2E7D5F664

P6179

Q37645358-58891ADA-9550-4118-A2E1-726CC15A1951

P698

Q37645358-3E986D05-F638-4F35-97F5-DEFAE48A067D

P921

Q37645358-76F9F026-5BD9-4049-AFDD-7BA15C5D8CA8

P932

Q37645358-0F7B63A8-7A64-4D56-9718-F3C1DD7E0707

P356

S13195-017-0234-1

P1433

Alzheimers Research & Therapy

P1476

The effects of different famil ...... ons on APP processing in vivo.

@en

P2093

Anne Kinhult Ståhlbom

http://www.w3.org/2001/XMLSchema#string

Håkan Thonberg

http://www.w3.org/2001/XMLSchema#string

Steinunn Thordardottir

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide.

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease

P2888

s13195-017-0234-1

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13195-017-0234-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Maria Eriksdotter

Henrik Zetterberg

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083845003

http://www.w3.org/2001/XMLSchema#string

P698

28209190

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5312523

http://www.w3.org/2001/XMLSchema#string